Back
Arbutus Biopharma 10K Form
Sell
36
ABUS
Arbutus Biopharma
Last Price:
3.50
Seasonality Move:
15.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-07 | 10Q | ABUS/Arbutus Biopharma Quarterly |
| 2023-08-03 | 10Q | ABUS/Arbutus Biopharma Quarterly |
| 2023-05-04 | 10Q | ABUS/Arbutus Biopharma Quarterly |
| 2022-11-09 | 10Q | ABUS/Arbutus Biopharma Quarterly |
| 2022-08-04 | 10Q | ABUS/Arbutus Biopharma Quarterly |
| 2022-05-05 | 10Q | ABUS/Arbutus Biopharma Quarterly |
Receive ABUS News And Ratings
See the #1 stock for the next 7 days that we like better than ABUS
ABUS Financial Statistics
Sales & Book Value
| Annual Sales: | $18.14M |
|---|---|
| Cash Flow: | $-20.74M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.56 |
| Price / Book: | 6.13 |
Profitability
| EPS (TTM): | -0.43000 |
|---|---|
| Net Income (TTM): | $-76.7M |
| Gross Margin: | $-40.57M |
| Return on Equity: | -67.36% |
| Return on Assets: | -50.88% |
Arbutus Biopharma Earnings Forecast
Key Arbutus Biopharma Financial Ratios
- The Gross Profit Margin over the past 12 years for ABUS is -586.78%.
- The Selling, General & Administrative Expenses for ABUS have been equal to 123.89% of Gross Profit Margin.
- The Research & Development expenses have been 406.26% of Revenue.
- The Interest Expense is -0.63% of Operating Income.
- The Net Earning history of ABUS is -401.57% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 16 years.
Arbutus Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ABUS |
| CUSIP: | 03879J |
| Website: | arbutusbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.02 |
| Quick Ratio: | 6.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ABUS Technical Analysis vs Fundamental Analysis
Sell
36
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a Sell
The current Arbutus Biopharma [ABUS] share price is $3.46. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.